The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
NFKB1: a suppressor of inflammation, ageing and cancer
Open accessAbstract
The pleiotropic consequences of nuclear factor of kappa light polypeptide gene enhancer in B‐cells (NF‐κB) pathway activation result from the combinatorial effects of the five subunits that form the homo‐ and heterodimeric NF‐κB complexes. Although biochemical and gene knockout studies have demonstrated overlapping and distinct functions for these proteins, much is still not known about the mechanisms determining context‐dependent functions, the formation of different dimer complexes and transcriptional control in response to diverse stimuli. Here we discuss recent results that reveal that the nuclear factor of kappa light polypeptide gene enhancer in B‐cells 1 (NFKB 1) (p105/p50) subunit is an important regulator of NF‐κB activity in vivo. These effects are not restricted to being a dimer partner for other NF‐κB subunits. Rather p50 homodimers have a critical role as suppressors of the NF‐κB response, while the p105 precursor has a variety of NF‐κB‐independent functions. The importance of Nfkb1 function can be seen in mouse models, where Nfkb1−/− mice display increased inflammation and susceptibility to certain forms of DNA damage, leading to cancer, and a rapid ageing phenotype. In humans, low expression of Kip1 ubiquitination‐promoting complex 1 (KPC 1), a ubiquitin ligase required for p105 to p50 processing, was shown to correlate with a reduction in p50 and glioblastoma incidence. Therefore, while the majority of research in this field has focused on the upstream signalling pathways leading to NF‐κB activation or the function of other NF‐κB subunits, such as RelA (p65), these data demonstrate a critical role for NFKB 1, potentially revealing new strategies for targeting this pathway in inflammatory diseases and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Self-citationCrosstalk in NF-κB Signaling Pathways
Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011) · Nature Immunology · doi:10.1038/ni.2065 · Cited by 1,942
NF‐κB and the link between inflammation and cancer
DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,482
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1
Zhong, H., May, M. J., Jimi, E., & Ghosh, S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00477-x · Cited by 939
The diverse and complex roles of NF-κB subunits in cancer
Perkins, N. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3204 · Cited by 852
Self-citationChronic inflammation induces telomere dysfunction and accelerates ageing in mice
Jurk, D., Wilson, C., Passos, J. F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5172 · Cited by 819
Self-citationRecognition and Signaling by Toll-Like Receptors
West, A. P., Koblansky, A. A., & Ghosh, S. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.115827 · Cited by 720
Das, J., Chen, C.-H., Yang, L., Cohn, L., Ray, P., & Ray, A. (2001) · Nature Immunology · doi:10.1038/83158 · Cited by 518
A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.
Baeuerle, P. A., & Baltimore, D. (1989) · Genes & Development · doi:10.1101/gad.3.11.1689 · Cited by 505
Inhibition of NF- B DNA Binding by Nitric Oxide
Matthews, J. R., Botting, C. H., Panico, M., Morris, H. R., & Hay, R. T. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.12.2236 · Cited by 495
Moynagh, P. N. (2005) · Journal of Cell Science · doi:10.1242/jcs.02579 · Cited by 489
Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ
Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K., et al. (2004) · Nature · doi:10.1038/nature02738 · Cited by 460
Mayya, V., Lundgren, D. H., Hwang, S.-I., Rezaul, K., Wu, L., Eng, J. K., Rodionov, V., & Han, D. K. (2009) · Science Signaling · doi:10.1126/scisignal.2000007 · Cited by 372
NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages
Cao, S., Zhang, X., Edwards, J. P., & Mosser, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602222200 · Cited by 370
Cockman, M. E., Lancaster, D. E., Stolze, I. P., Hewitson, K. S., McDonough, M. A., Coleman, M. L., Coles, C. H., Yu, X., Hay, R. T., Ley, S. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606877103 · Cited by 285
IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family
Inoue, J.-I., Kerr, L. D., Kakizuka, A., & Verma, I. M. (1992) · Cell · doi:10.1016/0092-8674(92)90082-n · Cited by 269
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome
Bian, Y., Song, C., Cheng, K., Dong, M., Wang, F., Huang, J., Sun, D., Wang, L., Ye, M., & Zou, H. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2013.11.014 · Cited by 251
Negative Regulation of Toll-Like Receptor Signaling by NF-κB p50 Ubiquitination Blockade
Carmody, R. J., Ruan, Q., Palmer, S., Hilliard, B., & Chen, Y. H. (2007) · Science · doi:10.1126/science.1142953 · Cited by 228
BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages
Wessells, J., Baer, M., Young, H. A., Claudio, E., Brown, K., Siebenlist, U., & Johnson, P. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404246200 · Cited by 197
NF-kappa B p105 is a target of Ikappa B kinases and controls signal induction of Bcl-3-p50 complexes
Heissmeyer, V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4766 · Cited by 197
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7818 · Cited by 171
Self-citationEnhancement of Nuclear Factor-κB Acetylation by Coactivator p300 and HIV-1 Tat Proteins
Furia, B., Deng, L., Wu, K., Baylor, S., Kehn, K., Li, H., Donnelly, R., Coleman, T., & Kashanchi, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107848200 · Cited by 167
Glycogen Synthase Kinase-3β Regulates NF-κB1/p105 Stability
Demarchi, F., Bertoli, C., Sandy, P., & Schneider, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305676200 · Cited by 162
Elsharkawy, A. M., Oakley, F., Lin, F., Packham, G., Mann, D. A., & Mann, J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.025 · Cited by 160
Savinova, O. V., Hoffmann, A., & Ghosh, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.033 · Cited by 159
IκBNS Inhibits Induction of a Subset of Toll-like Receptor-Dependent Genes and Limits Inflammation
Kuwata, H., Matsumoto, M., Atarashi, K., Morishita, H., Hirotani, T., Koga, R., & Takeda, K. (2006) · Immunity · doi:10.1016/j.immuni.2005.11.004 · Cited by 150
Ishikawa, H., Claudio, E., Dambach, D. M., Raventós-Suárez, C., Ryan, C. S., & Bravo, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.985 · Cited by 144
The 20S proteasome processes NF‐κB1 p105 into p50 in a translation‐independent manner
Moorthy, A. K., Savinova, O. V., Ho, J. Q., Wang, V. Y., Vu, D., & Ghosh, G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601081 · Cited by 140
Salmerón, A., Janzen, J., Soneji, Y., Bump, N. J., Kamens, J., Allen, H., & Ley, S. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101754200 · Cited by 128
NF-κB1 p105 Negatively Regulates TPL-2 MEK Kinase Activity
Beinke, S., Deka, J., Lang, V., Belich, M. P., Walker, P. A., Howell, S. A., Smerdon, S. J., Gamblin, S. J., & Ley, S. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.14.4739-4752.2003 · Cited by 124
Nuclear Factor-κB1 (p50) Limits the Inflammatory and Fibrogenic Responses to Chronic Injury
Oakley, F., Mann, J., Nailard, S., Smart, D. E., Mungalsingh, N., Constandinou, C., Ali, S., Wilson, S. J., Millward-Sadler, H., Iredale, J. P., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62291-2 · Cited by 123
KPC1-Mediated Ubiquitination and Proteasomal Processing of NF-κB1 p105 to p50 Restricts Tumor Growth
Kravtsova-Ivantsiv, Y., Shomer, I., Cohen-Kaplan, V., Snijder, B., Superti-Furga, G., Gonen, H., Sommer, T., Ziv, T., Admon, A., Naroditsky, I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.001 · Cited by 117
A New Member of the IκB Protein Family, IκBε, Inhibits RelA (p65)-Mediated NF-κB Transcription
Li, Z., & Nabel, G. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.6184 · Cited by 117
Watanabe, N., Iwamura, T., Shinoda, T., & Fujita, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3609 · Cited by 111
Loss of Nfkb1 leads to early onset aging
Bernal, G. M., Wahlstrom, J. S., Crawley, C. D., Cahill, K. E., Pytel, P., Liang, H., Kang, S., Weichselbaum, R. R., & Yamini, B. (2014) · Aging · doi:10.18632/aging.100702 · Cited by 97
Cheng, C. S., Feldman, K. E., Lee, J., Verma, S., Huang, D.-B., Huynh, K., Chang, M., Ponomarenko, J. V., Sun, S., Benedict, C. A., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001501 · Cited by 95
Phosphorylation of Serine 337 of NF-κB p50 Is Critical for DNA Binding
Hou, S., Guan, H., & Ricciardi, R. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307971200 · Cited by 91
Bcl-3 and NFκB p50-p50 Homodimers Act as Transcriptional Repressors in Tolerant CD4+ T Cells
Grundström, S., Anderson, P. O., Scheipers, P., & Sundstedt, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312398200 · Cited by 88
Artis, D., Shapira, S. D., Mason, N. J., Speirs, K. M., Goldschmidt, M. H., Caamaño, J., Liou, H., Hunter, C. A., & Scott, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4481 · Cited by 81
O’Keeffe, M. A., Grumont, R. J., Hochrein, H., Fuchsberger, M., Gugasyan, R., Vremec, D., Shortman, K., & Gerondakis, S. (2005) · Blood · doi:10.1182/blood-2004-12-4965 · Cited by 81
NF-κB p50 Regulates C/EBPα Expression and Inflammatory Cytokine-Induced Neutrophil Production
Wang, D., Paz‐Priel, I., & Friedman, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803861 · Cited by 74
Trinh, D. V., Zhu, N., Farhang, G., Kim, B., & Huxford, T. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.03.060 · Cited by 73
Proteolysis of NF-κB1 p105 is essential for T cell antigen receptor–induced proliferation
Sriskantharajah, S., Belich, M. P., Papoutsopoulou, S., Janzen, J., Tybulewicz, V. L. J., Seddon, B. P., & Ley, S. C. (2008) · Nature Immunology · doi:10.1038/ni.1685 · Cited by 71
Characterization of the Dimer Interface of Transcription Factor NFκB p50 Homodimer
Sengchanthalangsy, L. L., Datta, S., Huang, D.-B., Anderson, E., Braswell, E. H., & Ghosh, G. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2823 · Cited by 67
Zaph, C., Rook, K. A., Goldschmidt, M. H., Mohrs, M., Scott, P., & Artis, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.511 · Cited by 67
Coordinate Regulation of TPL-2 and NF-κB Signaling in Macrophages by NF-κB1 p105
Yang, H., Papoutsopoulou, S., Belich, M. P., Brender, C., Janzen, J., Gantke, T., Handley, M., & Ley, S. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00564-12 · Cited by 67
Nuclear Factor-κB p50 Limits Inflammation and Prevents Lung Injury during Escherichia coli Pneumonia
Mizgerd, J. P., Lupa, M. M., Kogan, M. S., Warren, H. B., Kobzik, L., & Topulos, G. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200303-412oc · Cited by 66
Resolution of renal inflammation: a new role for NF-κB1 (p50) in inflammatory kidney diseases
Panzer, U., Steinmetz, O. M., Turner, J., Meyer‐Schwesinger, C., von Ruffer, C., Meyer, T. N., Zahner, G., Gómez‐Guerrero, C., Schmid, R. M., Helmchen, U. M., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90435.2008 · Cited by 64
Artis, D., Kane, C. M., Fiore, J., Zaph, C., Shapira, S. D., Joyce, K. L., MacDonald, A. S., Hunter, C. A., Scott, P., & Pearce, E. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7154 · Cited by 58
NF-κB1 p105 Regulates T Cell Homeostasis and Prevents Chronic Inflammation
Chang, M., Lee, A. J., Fitzpatrick, L. R., Zhang, M., & Sun, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803637 · Cited by 56
Bressler, P. B., Brown, K. D., TIMMER, W. G., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.288-293.1993 · Cited by 54
p50 (NF-κB1) Is an Effector Protein in the Cytotoxic Response to DNA Methylation Damage
Schmitt, A. M., Crawley, C. D., Kang, S., Raleigh, D. R., Yu, X., Wahlstrom, J. S., Voce, D. J., Darga, T. E., Weichselbaum, R. R., & Yamini, B. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.026 · Cited by 53
Collins, P. E., Kiely, P. A., & Carmody, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551986 · Cited by 52
IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer
Tsui, R., Kearns, J. D., Lynch, C., Vu, D., Ngo, K. A., Basak, S., Ghosh, G., & Hoffmann, A. (2015) · Nature Communications · doi:10.1038/ncomms8068 · Cited by 48
Paz‐Priel, I., Houng, S., Dooher, J. E., & Friedman, A. D. (2011) · Blood · doi:10.1182/blood-2010-07-294470 · Cited by 45
Perugorria, M. J., Murphy, L. B., Fullard, N., Chakraborty, J. B., Vyrla, D., Wilson, C. L., Oakley, F., Mann, J., & Mann, D. A. (2012) · Hepatology · doi:10.1002/hep.26108 · Cited by 44
EHMT1 Protein Binds to Nuclear Factor-κB p50 and Represses Gene Expression
Ea, C.-K., Hao, S., Yeo, K. S., & Baltimore, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365601 · Cited by 44
Physical interaction of the bHLH LYL1 protein and NF-κB1 p105
Ferrier, R., Nougarède, R., Doucet, S., Kahn‐Perlès, B., Imbert, J., & Mathieu-Mahul, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202374 · Cited by 40
Rõlova, T., Puli, L., Magga, J. M., Dhungana, H., Kanninen, K. M., Wojciehowski, S., Salminen, A., Tanila, H., Koıstınaho, J., & Malm, T. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.12.003 · Cited by 36
Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor
Voce, D. J., Schmitt, A. M., Uppal, A., McNerney, M. E., Bernal, G. M., Cahill, K. E., Wahlstrom, J. S., Nassiri, A., Yu, X., Crawley, C. D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.211 · Cited by 34
NF-κB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation
Mizgerd, J. P., Lupa, M. M., & Spieker, M. R. (2004) · BMC Immunology · doi:10.1186/1471-2172-5-10 · Cited by 33
Babu, G. R., Jin, W., Norman, L. P., Waterfield, M. R., Chang, M., Wu, X., Zhang, M., & Sun, S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.12.010 · Cited by 32
Southern, S. L., Collard, T. J., Urban, B. C., Skeen, V. R., Smartt, H. J. M., Hague, A., Oakley, F., Townsend, P. A., Perkins, N. D., Paraskeva, C., et al. (2011) · Oncogene · doi:10.1038/onc.2011.452 · Cited by 29
Self-citationCrawley, C. D., Raleigh, D. R., Kang, S., Voce, D. J., Schmitt, A. M., Weichselbaum, R. R., & Yamini, B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1120 · Cited by 28
Identification of a ZU5 and Death Domain-containing Inhibitor of NF-κB
Zhang, J., Xu, L., Han, K.-J., & Shu, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310737200 · Cited by 22
Casper/c-FLIP is physically and functionally associated with NF-κB1 p105
Li, Z., Zhang, J., Chen, D., & Shu, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.104 · Cited by 22
Crawley, C. D., Kang, S., Bernal, G. M., Wahlstrom, J. S., Voce, D. J., Cahill, K. E., Garofalo, A., Raleigh, D. R., Weichselbaum, R. R., & Yamini, B. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991166 · Cited by 17
Cited by
Grieshaber-Bouyer, R., Radtke, F. A., Cunin, P., Stifano, G., Levescot, A., Vijaykumar, B., Nelson-Maney, N., Blaustein, R. B., Monach, P. A., Nigrovic, P. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22973-9 · Cited by 344
NF-κB in monocytes and macrophages – an inflammatory master regulator in multitalented immune cells
Mussbacher, M., Derler, M., Basílio, J., & Schmid, J. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1134661 · Cited by 320
Rapamycin improves healthspan but not inflammaging in nfκb1−/− mice
Correia‐Melo, C., Birch, J., Fielder, E., Rahmatika, D., Taylor, J., Chapman, J., Lagnado, A., Carroll, B. M., Miwa, S., Richardson, G., et al. (2019) · Aging Cell · doi:10.1111/acel.12882 · Cited by 77
Ressa, A., Bosdriesz, E., de Ligt, J., Mainardi, S., Maddalo, G., Prahallad, A., Jager, M., de la Fonteijne, L., Fitzpatrick, M., Groten, S., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000486 · Cited by 17
Metadata
- Authors
- Cartwright, T., Perkins, N. D., & L. Wilson, C.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2016-01-13
- Volume
- 283
- Issue
- 10
- Pages
- 1812-1822
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2284475971
- Cited by
- 347
- References
- 70
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.